Zydus Lifesciences gets Health Canada approval for generic mesalamine suppositories 1000 mg

The Mesalamine suppositories will be manufactured at Zydus Lifesciences’ facility in Changodar, Ahmedabad, Gujarat. Shares of Zydus Lifesciences Ltd ended at ₹1,004.90, down by ₹4.10, or 0.41%, on the BSE.

Source link